RFI for CERCLA Enforcement Support Services Contract

The Environmental Protection Agency (EPA) Region 9 has issued a Request for Information (RFI) for CERCLA Enforcement Support Services. This RFI seeks input from potential contractors to help define requirements for a contract supporting CERCLA enforcement activities.

SAM.gov Notice: Post-fire Recovery Project Management BPA Call Order

The Forest Service intends to issue a competitive BPA Call Order under the Land Management Integrated Resources (LMIR) BPA for post-fire recovery project management services on the Carson National Forest. This notice is a synopsis of intent and not a request for proposals.

EU Implementing Regulations and Decisions - March 25, 2026

The European Union has published several implementing regulations and decisions in the Official Journal L series dated March 25, 2026. These include cancellations of protected geographical indications, extensions of anti-dumping duties on imports from China, entry of a new PGI, amendments to animal product import regulations, and a decision on financial services within the EEA.

FEMA Reinstates $1B BRIC Grant Program After Court Ruling

The North Carolina Attorney General's office announced that FEMA has conceded to a court ruling and will reinstate the Building Resilient Infrastructure and Communities (BRIC) program. This decision will make approximately $1 billion in new grants available for water, sewer, and flood protection projects.

EPO Patent EP3601341A1: Antibodies Against Human FSHR Extracellular Domain

The European Patent Office has published patent application EP3601341A1 concerning antibodies against the human FSHR extracellular domain. The patent is assigned to FSHR Theranostics and lists Nicolae Ghinea as the inventor. The publication date is March 11, 2026.

EPO Patent EP3727468A1: AAV-mediated delivery of therapeutic antibodies to inner ear

The European Patent Office has published patent application EP3727468A1 concerning AAV-mediated delivery of therapeutic antibodies to the inner ear. The patent is assigned to Akouos, Inc. and lists Emmanuel J. Simons, Robert Ng, and Michael McKenna as inventors.

Patent EP3690038A1: Antibody Pyrrolidobenzodiazepine Derivative Conjugate

The European Patent Office has published patent application EP3690038A1 for an "Antibody Pyrrolidobenzodiazepine Derivative Conjugate" filed by Daiichi Sankyo Company, Limited. This publication relates to a new class of therapeutic compounds.

EPO Patent Bulletin - Hybridoma Clones and Monoclonal Antibodies

The European Patent Office has published patent application EP3645042A2 concerning hybridoma clones, monoclonal antibodies to Vsig-4, and methods of making and using them. The patent is assigned to Bio-Techne Corporation and lists multiple inventors.

EPO Patent Bulletin: Stable Formulations of Antibodies to PD-1

The European Patent Office has published patent application EP3398612A1 concerning stable formulations of antibodies to human programmed death receptor PD-1 and related treatments. The application was published on March 11, 2026, with Merck Sharp & Dohme LLC listed as the applicant.

Regeneron Pharmaceuticals Cell Depletion Patent EP3471772A1

The European Patent Office has published patent application EP3471772A1 for Regeneron Pharmaceuticals, Inc. concerning compositions and methods for the depletion of cells. The patent application was published on March 11, 2026.